Canature Health(SZ:300272)2024-09-13 09:35Group 1: Financial Performance and R&D Investment - In the first half of 2024, the R&D expenses amounted to 20.2 million yuan, indicating a commitment to cutting-edge energy-saving technology development [1] - The company aims to enhance product capabilities through continuous investment in R&D [1] Group 2: Market Position and Strategy - The domestic market penetration rate for drinking water purification is currently at 20%, compared to 80-90% in Europe and the U.S., highlighting significant growth potential in the domestic market [2] - The company plans to adopt a "dual-energy drive" strategy, integrating water health and cellular health to provide a comprehensive health experience for customers [1] Group 3: Industry Challenges and Responses - The company is actively monitoring raw material price fluctuations and adjusting product prices accordingly to maintain profitability [2] - The original energy cell group is still in the preparatory stage for listing, with timely disclosures planned as necessary [2] Group 4: Future Development and Expansion - The company is open to strategic collaborations with other enterprises or institutions to enhance industry partnerships [3] - There are considerations for expanding into related fields such as water ecological management and wastewater treatment [3]